GMAT Question of the Day - Daily to your Mailbox; hard ones only

 It is currently 22 Feb 2019, 20:53

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

## Events & Promotions

###### Events & Promotions in February
PrevNext
SuMoTuWeThFrSa
272829303112
3456789
10111213141516
17181920212223
242526272812
Open Detailed Calendar
• ### Free GMAT RC Webinar

February 23, 2019

February 23, 2019

07:00 AM PST

09:00 AM PST

Learn reading strategies that can help even non-voracious reader to master GMAT RC. Saturday, February 23rd at 7 AM PT
• ### FREE Quant Workshop by e-GMAT!

February 24, 2019

February 24, 2019

07:00 AM PST

09:00 AM PST

Get personalized insights on how to achieve your Target Quant Score.

# The government health service has said that it definitely will not pay

Author Message
TAGS:

### Hide Tags

Director
Joined: 30 Jan 2016
Posts: 932
Location: United States (MA)
The government health service has said that it definitely will not pay  [#permalink]

### Show Tags

20 Feb 2018, 09:23
1
2
00:00

Difficulty:

45% (medium)

Question Stats:

60% (01:35) correct 40% (01:59) wrong based on 209 sessions

### HideShow timer Statistics

The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

(A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
(B) Antinfia will never be in widespread circulation.
(C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
(D) The government health service should pay for patients to take Antinfia.
(E) Antinfia is not cost-effective.

Source: LSAT

_________________

Non progredi est regredi

Board of Directors
Joined: 01 Sep 2010
Posts: 3352
Re: The government health service has said that it definitely will not pay  [#permalink]

### Show Tags

20 Feb 2018, 09:29
Top Contributor
Due to its circular reasoning, the only valid option is B. Actually, the drug will not be on the market.

However, notice how this is for LSAT but is not so much suitable for GMAT. The wording of an official question (especially in the latest OGs) is quite different.

Regards
_________________
VP
Status: It's near - I can see.
Joined: 13 Apr 2013
Posts: 1405
Location: India
GMAT 1: 480 Q38 V22
GPA: 3.01
WE: Engineering (Real Estate)
The government health service has said that it definitely will not pay  [#permalink]

### Show Tags

11 Apr 2018, 22:55
Akela wrote:
The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

(A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
(B) Antinfia will never be in widespread circulation.
(C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
(D) The government health service should pay for patients to take Antinfia.
(E) Antinfia is not cost-effective.

Source: LSAT

Not able to understand and infer properly. Though this is an LSAT question, there must me correct reasoning for the right answer.

Please help and also let us know whether such questions can be tested on GMAT or not.

VeritasPrepKarishma, GMATNinja
_________________

"Do not watch clock; Do what it does. KEEP GOING."

Veritas Prep GMAT Instructor
Joined: 16 Oct 2010
Posts: 8895
Location: Pune, India
Re: The government health service has said that it definitely will not pay  [#permalink]

### Show Tags

12 Apr 2018, 00:08
1
QZ wrote:
Akela wrote:
The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

(A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
(B) Antinfia will never be in widespread circulation.
(C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
(D) The government health service should pay for patients to take Antinfia.
(E) Antinfia is not cost-effective.

Source: LSAT

Not able to understand and infer properly. Though this is an LSAT question, there must me correct reasoning for the right answer.

Please help and also let us know whether such questions can be tested on GMAT or not.

VeritasPrepKarishma, GMATNinja

Yes, the reasoning is proper.

Argument tells us:

- Govt says it will not pay for Antinfia until PharmCo provides details on cost effectiveness.
- PharmCo says it can provide these details only if the Govt pays for Antinfia.

So basically they are caught in a circle. Hence, if both these statements are assumed to be true, the Govt will not pay for Antinfia and it will never be in widespread circulation (since the Govt needs to pay for it to be in widespread circulation). So (B) is correct.

(A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
We don't know this. We only know that they have refused to pay for Antinfia until its cost effectiveness is proven.

(C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
We don't know what patients will do. Out of scope.

(D) The government health service should pay for patients to take Antinfia.
Should or should not is not our call. We need to find what is true according to argument.

(E) Antinfia is not cost-effective.
The argument doesn't say that. PharmCo just needs widespread circulation to prove that it is cost-effective.
_________________

Karishma
Veritas Prep GMAT Instructor

Manager
Joined: 03 Apr 2016
Posts: 92
Location: India
Schools: ISB '19, IIMB EPGP"20
GMAT 1: 580 Q43 V27
GMAT 2: 650 Q32 V48
GRE 1: Q160 V151
GPA: 3.99
WE: Design (Consulting)
Re: The government health service has said that it definitely will not pay  [#permalink]

### Show Tags

12 Apr 2018, 09:07
Akela wrote:
The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

(A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
(B) Antinfia will never be in widespread circulation.
(C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
(D) The government health service should pay for patients to take Antinfia.
(E) Antinfia is not cost-effective.

Source: LSAT

The stimulus basically means, government doesn't give money if the drug is not cost effective and company can't say the drug is cost effective until government gives money. So they have reached an impasse. This means the drug will never get a widespread circulation. option B.
Re: The government health service has said that it definitely will not pay   [#permalink] 12 Apr 2018, 09:07
Display posts from previous: Sort by